Furthermore, because PAK2 and PAK4 have been related to pancreatic cancer, these two p21-activated kinases could be considered a prognostic and immunotherapeutic marker pancreatic cancer; therefore, future research in this direction should be necessary. This evidence concerns the gene PAK2 and familial pancreatic carcinoma.